Evidence map›Paper›PMID 39825390›Full record

ReviewJournal of eating disorders2025

Redefining diagnostic parameters: the role of overvaluation of shape and weight in binge-eating disorder: a systematic review.

Bernou Melisse, Alexandra Dingemans

Abstract readReview
In one paragraph

Review in Journal of eating disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Design, Implement, Sustain: Advancing Program-Led Interventions for Binge Eating, a Narrative Review.European eating disorders review : the journal of the Eating Disorders Association · 2026
    Review
  3. Article
  4. Bulimia nervosa.Nature reviews. Disease primers · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bernou MelisseAmerican Center for Psychiatry and Neurology, Al-Manhal, Abu Dhabi, United Arab Emirates. bernoumelisse@outlook.com.ORCID http://orcid.org/0000-0003-2636-5262
Alexandra DingemansGGZ Rivierduinen Eating Disorders Ursula, Sandifortdreef 19, 2333 AK, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-5499-7139

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOvervaluation of shape and weight is a critical component in understanding and diagnosing eating disorders. While the transdiagnostic model states that overvaluation of shape and weight is the core pathology of all eating disorders, this concept is not a criterion for binge-eating disorder. The lack of recognition of overvaluation of shape and weight may lead to overlooking, and consequently failure to address this construct during treatment. The aim of the present review is to examine whether overvaluation is a critical component in understanding and diagnosing binge-eating disorder and whether it should be addressed during treatment, and therefore be added as a criterion of binge-eating disorder.

methodsThe present review was registered in the International Prospective Register of Systematic Reviews (registration number: CRD42024541433). PsycINFO, Web of Science, PubMed (Medline), and Google Scholar were used in order to systematically search and review literature by using a list of keywords related to overvaluation of shape and weight and binge-eating disorder. All N = 93 peer-reviewed studies were published in English from 1993 onwards.

resultsOvervaluation of shape and weight was more severe among individuals with binge-eating disorder compared to individuals with solely a similar high BMI. In addition, levels of overvaluation in binge-eating disorder were comparable in severity with that of individuals of the other named eating disorder subtypes. Overvaluation was positively associated with other psychiatric symptoms, a risk factor for the onset of binge eating in adolescents and predicted poorer treatment outcomes. It was not clear whether overvaluation predicted dropout from Cognitive Behavior Therapy interventions. DISCUSSION: It is suggested to consider including overvaluation of shape and weight as a criterion for the diagnosis of binge-eating disorder. Including overvaluation in the DSM and ICD may prevent overlooking this construct, and potentially enhance treatment outcomes. It is suggested that overvaluation of shape and weight is the core pathology of all eating disorders. However, this concept is not a criterion for a binge-eating disorder diagnosis. The lack of recognition of overvaluation of shape and weight may lead to overlooking, and consequently failure to address this construct during treatment. The aim of the present review is to examine whether overvaluation is a critical component in understanding and diagnosing binge-eating disorder and whether it should be addressed during treatment, and therefore be added as a criterion of binge-eating disorder. Consequently, a total of N = 93 peer-reviewed studies were examined. It was found that overvaluation of shape and weight was associated with the severity of eating disorder psychopathology, and was comparable in severity with that of individuals diagnosed with anorexia nervosa and bulimia nervosa. There is enough evidence to include overvaluation in the DSM and ICD as a criterion for binge-eating disorder. Consequently, this may prevent overlooking this construct, and potentially enhance treatment outcomes.

Indexed as

Binge-eating disorderOvervaluation of shape and weightPrevalenceSystematic reviewTreatment outcomes

Identifiers

PMID39825390
PMCPMC11748573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.